Exploring the Efficacy and Feasibility of the LymphaTech Scanner for Breast Cancer-Related Lymphedema Screening

This will be a prospective trial to assess arm edema using the LymphaTech Scanner, perometry,
and a comprehensive self-report questionnaire in a cohort of patients who have been diagnosed
with invasive or in-situ carcinoma of the breast

Inclusion Criteria:

- Participants must have histologically or cytologically confirmed invasive or in-situ
carcinoma of the breast and will undergo unilateral breast cancer surgery

- Willingness to complete SEI-BCLE Questionnaire

- Age >18 years.

- Ability to understand and the willingness to verbally consent to the trial

Exclusion Criteria:

- History of primary lymphedema.

- Any patient with a current case of cellulitis.

- Participants with known brain metastases should be excluded from this clinical trial
because of their poor prognosis and because they often develop progressive neurologic
dysfunction that would confound the evaluation of neurologic and other adverse events.

- Uncontrolled intercurrent illness including, but not limited to, ongoing or active
infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac
arrhythmia, or psychiatric illness/social situations that would limit compliance with
study requirements.

- Participants unable to abduct upper-extremity perpendicular to body or to stand
comfortably without aid for several minutes, both of which are necessary to perform a
LymphaTech Scan